title: Approval of alteplase in Europe: will it change stroke management?
authors.affiliation: Department of Neurology, Helsinki University Central Hospital, FIN-00029 HUS, Helsinki, Finland. markku.kaste@hus.fi <markku.kaste@hus.fi>
authors.forename: Markku
authors.initials: M
authors.lastname: Kaste
mesh_terms: D017277:Drug Approval; D005060:Europe; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D010818:Practice Patterns, Physicians'; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator